brostallicin: Clinical Trials

5 trials of brostallicin, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

3 completed, 2 unknown. 5 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 25Completed 3, Unknown 2
Phase 11Completed 1

Follow brostallicin: new trials by email Literature Review of brostallicin trials Research Report on brostallicin

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Brostallicin and Cisplatin in Treating Patients With Metastatic Breast Cancer
brostallicin, cisplatin - Triple-negative Breast Cancer
Phase 2CompletedAlliance for Clinical Trials in Oncology482010-06-012018-05-08
Brostallicin Clinical Trial for Myxoid Liposarcoma
Brostallicin - Myxoid Liposarcoma
Phase 2UnknownSystems Medicine LLC242007-08-012010-02-26
Brostallicin or Doxorubicin as First-Line Therapy in Treating Patients With Relapsed, Refractory, or Metastatic Soft Tissue Sarcoma
brostallicin, doxorubicin hydrochloride - Ovarian Cancer, Sarcoma
Phase 2UnknownEuropean Organisation for Research and Treatment of Cancer - EORTC1182006-10-012014-08-08
Brostallicin in Treating Patients With Recurrent or Refractory Multiple Myeloma
brostallicin - Multiple Myeloma and Plasma Cell Neoplasm
Phase 1 / Phase 2CompletedCase Comprehensive Cancer Center32002-12-012014-01-16
Brostallicin in Treating Patients With Locally Advanced or Metastatic Soft Tissue Sarcoma
brostallicin - Gastrointestinal Stromal Tumor, Sarcoma
Phase 2CompletedEuropean Organisation for Research and Treatment of Cancer - EORTC642002-05-012012-07-18

Conditions studied

Sarcoma (3)  ·  Fibrosarcoma (2)  ·  Hemangiosarcoma (2)  ·  Histiocytoma, Malignant Fibrous (2)  ·  Leiomyosarcoma (2)  ·  Liposarcoma (2)  ·  Neurofibrosarcoma (2)  ·  Rhabdomyosarcoma (2)  ·  Sarcoma, Synovial (2)  ·  Breast Neoplasms (1)  ·  Breast Neoplasms, Male (1)  ·  Gastrointestinal Stromal Tumors (1)  ·  Hemangiopericytoma, Malignant (1)  ·  Liposarcoma, Myxoid (1)  ·  Malignant mesenchymal tumor (1)

Sponsors

European Organisation for Research and Treatment of Cancer - EORTC (2)  ·  Alliance for Clinical Trials in Oncology (1)  ·  Case Comprehensive Cancer Center (1)  ·  Systems Medicine LLC (1)

Countries

United States (3)  ·  Netherlands (2)  ·  Belgium (1)  ·  France (1)  ·  Germany (1)  ·  United Kingdom (1)

Top investigators

Alvaro Moreno Aspitia, MD (1)  ·  Hans Gelderblom, MD, PhD (1)  ·  Hillard M. Lazarus, MD (1)  ·  Jack Singer, M.D. (1)  ·  Michael Leahy, MBChB, FRACP, FRCP, FRC Path (1)

Results publications

PMID 17095209, PMID 24215845